| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1829 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 287 | 2021 |
| COVID-19 and cancer: current challenges and perspectives Z Bakouny, JE Hawley, TK Choueiri, S Peters, BI Rini, JL Warner, ... Cancer cell 38 (5), 629-646, 2020 | 259 | 2020 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 142 | 2020 |
| COVID-19 vaccination and breakthrough infections in patients with cancer AL Schmidt, C Labaki, CY Hsu, Z Bakouny, N Balanchivadze, SA Berg, ... Annals of oncology 33 (3), 340-346, 2022 | 90 | 2022 |
| Blocking IL1 beta promotes tumor regression and remodeling of the myeloid compartment in a renal cell carcinoma model: multidimensional analyses DH Aggen, CR Ager, AZ Obradovic, N Chowdhury, A Ghasemzadeh, ... Clinical Cancer Research 27 (2), 608-621, 2021 | 88 | 2021 |
| COVID-19 and Cancer Consortium NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study …, 2020 | 57 | 2020 |
| Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City K Kalinsky, MK Accordino, K Hosi, JE Hawley, MS Trivedi, KD Crew, ... Breast cancer research and treatment 182, 239-242, 2020 | 56 | 2020 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 40 | 2021 |
| Design and implementation of an affordable, public sector electronic medical record in rural Nepal A Raut, C Yarbrough, V Singh, B Gauchan, D Citrin, V Verma, J Hawley, ... Journal of Innovation in Health Informatics 24 (2), 862, 2017 | 35 | 2017 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 30 | 2023 |
| B7-H3 as a therapeutic target in advanced prostate cancer C Guo, I Figueiredo, B Gurel, A Neeb, G Seed, M Crespo, S Carreira, ... European urology 83 (3), 224-238, 2023 | 27 | 2023 |
| A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance M Abidi, DM Aboulafia, MK Accordino, JD Acoba, MS Ahluwalia, ... Cancer cell 38 (6), 761-766, 2020 | 18 | 2020 |
| LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19) P Grivas, J Warner, Y Shyr, D Shah, SM Rubinstein, NM Kuderer, ... Annals of Oncology 31, S1202-S1203, 2020 | 16 | 2020 |
| Reversible epigenetic alterations mediate PSMA expression heterogeneity in advanced metastatic prostate cancer E Sayar, RA Patel, IM Coleman, MP Roudier, A Zhang, P Mustafi, JY Low, ... JCI insight 8 (7), 2023 | 14 | 2023 |
| Racial disparities in the surgical treatment of clinical stage I non-small cell lung cancer among veterans BT Heiden, DB Eaton Jr, SH Chang, Y Yan, AA Baumann, MW Schoen, ... Chest 162 (4), 920-929, 2022 | 11 | 2022 |
| Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy JE Hawley, S Pan, WD Figg, ZA Lopez‐Bujanda, JD Strope, DH Aggen, ... The Prostate 80 (4), 336-344, 2020 | 11 | 2020 |
| The impact of androgen deprivation therapy on COVID-19 illness in men with prostate cancer NJ Shah, VG Patel, X Zhong, L Pina, JE Hawley, E Lin, BA Gartrell, ... JNCI cancer spectrum 6 (3), pkac035, 2022 | 10 | 2022 |
